Identification of New Biomarkers of Low-Dose GH Replacement Therapy in GH-Deficient Patients

CONTEXT: GH secretion peaks at puberty and continues to be secreted in adulthood, albeit at a declining rate. Profound GH deficiency (GHD) in adults with pituitary disease is associated with symptoms that improve with GH substitution, but it is important to tailor the GH dose to avoid overtreatment....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cruz-Topete, Diana, Jorgensen, Jens Otto L., Christensen, Britt, Sackmann-Sala, Lucila, Krusenstjerna-Hafstrøm, Thomas, Jara, Adam, Okada, Shigeru, Kopchick, John J.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2011
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205513/
https://ncbi.nlm.nih.gov/pubmed/21543428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-0197
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars